1-carboxyglutamic acid has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, H; Li, YK; Xu, G; Xu, RZ; Xu, XY; Zhen, YF | 1 |
| Muñoz-Valle, JF; Sánchez-Enríquez, S; Villafán-Bernal, JR | 1 |
1 review(s) available for 1-carboxyglutamic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Molecular modulation of osteocalcin and its relevance in diabetes (Review).
Topics: 1-Carboxyglutamic Acid; Adiponectin; Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glucose Tolerance Test; Glycemic Index; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Osteocalcin; Sequence Analysis, DNA; Transcription, Genetic | 2011 |
1 other study(ies) available for 1-carboxyglutamic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Decreased serum undercarboxylated osteocalcin is associated with cognitive impairment in male patients with type 2 diabetes.
Topics: 1-Carboxyglutamic Acid; Adult; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Male; Middle Aged; Neuropsychological Tests; Osteocalcin; Risk Factors | 2018 |